This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment. Serious ...

Eli Lilly announced that the Food and Drug Administration (FDA) has approved Taltz (ixekizumab) injection for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for ...

Please provide your email address to receive an email when new articles are posted on . A citrate-free formulation of Taltz injection for patients is now available following its FDA approval earlier ...

--Eli Lilly and Company today announced positive topline results from the novel TOGETHER-PsA open-label Phase 3 b trial evaluating the concomitant use of Taltz and Zepbound compared to Taltz alone in ...

Taltz may be administered alone or in combination with a conventional disease-modifying antirheumatic drug, such as methotrexate. The Food and Drug Administration (FDA) has approved Taltz (ixekizumab; ...

Taltz (ixekizumab) is a brand-name prescription drug that treats certain types of arthritis and psoriasis. The cost of Taltz with and without insurance can depend on several factors, such as whether ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...

Taltz is a prescription drug used to treat plaque psoriasis and certain types of arthritis. Taltz is an immunosuppressant. Learn what that means and other details about the drug. Taltz belongs to a ...

Taltz can interact with abatacept (Orencia), canakinumab (Ilaris), tofacitinib (Xeljanz, Xeljanz XR), and upadacitinib (Rinvoq). Taking any of these medications with Taltz can make you more likely to ...

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance (PASI 100) and ≥10% weight loss In ...